In the wake of the Feb. 20 U.S. Supreme Court ruling striking down Trump's use of the International Emergency Economic Powers Act tariffs, India will likely delay implementing its trade deal with the United States while seeking opportunities to expand its Russian oil imports, but this will create a lingering risk of pharmaceutical tariffs. On Feb. 26, U.S. Secretary of Commerce Howard Lutnick met with Indian Commerce Minister Piyush Goyal in New Delhi to discuss trade. India and the United States had announced they reached a trade deal Feb. 2, under which U.S. President Donald Trump reduced the levy on Indian goods from 25% to 18% and eliminated the additional 25% duty India faced for importing Russian oil. A meeting to finalize the U.S.